Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with lewy bodies, and multiple system atrophy

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 4, 2009, Pages 365-370

  Kao, Aimee W ^a   Racine, Caroline A ^a   Quitania, Lovingly C ^a   Kramer, Joel H ^a   Christine, Chadwick W ^a   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

synuclein; Dementia; Dementia with Lewy bodies; Multiple system atrophy; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DELUSION; DEMENTIA; DEPRESSION; DEPTH PERCEPTION; FEMALE; FUNCTIONAL DISEASE; HUMAN; LEWY BODY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; SHY DRAGER SYNDROME;

AGED; ALPHA-SYNUCLEIN; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MEMORY; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 75949111774     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181b5065d     Document Type: Article

References (41)

1. Spillantini MG, Crowther RA, Jakes R, et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett. 1998;251:205-208. (Pubitemid 28381082)
2. Nutt JG, Wooten GF. Clinical practice. Diagnosis and initial management of Parkinson's disease. N Engl J Med. 2005; 353:1021-1027.
3. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999; 163:94-98. (Pubitemid 29155424)
4. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
5. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770-2788.
6. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197-211.
7. Gomez-Tortosa E, Newell K, Irizarry MC, et al. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 1999;53:1284-1291.
8. Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA). J Neural Transm. 2004;111:485-495.
9. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005;20(suppl 12):S29-S36.
10. Norris EH, Giasson BI, Lee VM. Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol. 2004;60:17-54.
11. Marti MJ, Tolosa E, Campdelacreu J. Clinical overview of the synucleinopathies. Mov Disord. 2003;18(suppl 6):S21-S27.
12. Lauterbach EC. The neuropsychiatry of Parkinson's disease and related disorders. Psychiatr Clin North Am. 2004;27: 801-825.
13. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33-39.
14. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670-676.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
16. Reitan RM. The validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958; 8:271-276.
17. Kramer JH, Jurik J, Sha SJ, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol. 2003;16:211-218.
18. Golden CJ. Identification of brain disorders by the Stroop Color and Word Test. J Clin Psychol. 1976;32:654-658.
19. Delis DC, Kramer JH, Kaplan E, et al. Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc. 2004;10:301-303.
20. Delis DC, Wetter SR, Jacobson MW, et al. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. J Int Neuropsychol Soc. 2005;11: 708-715.
21. Delis DC, Kramer JH, Kaplan E, et al. CVLT II: Second Edition. San Antonio, TX: The Psychological Corporation; 2000.
22. Graves RE, Bezeau SC, Fogarty J, et al. Boston naming test short forms: a comparison of previous forms with new item response theory based forms. J Clin Exp Neuropsychol. 2004; 26:891-902.
23. Boxer AL, Kramer JH, Du AT, et al. Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology. 2003;61:1485-1491.
24. Rapport LJ, Millis SR, Bonello PJ. Validation of the Warrington theory of visual processing and the visual object and space perception battery. J Clin Exp Neuropsychol. 1998; 20:211-220.
25. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37-49.
26. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323-329.
27. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48: S10-S16.
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc (Ser B). 1995;57:289-300.
29. Diagnostic and Statistical Manual of Mental Disorders DSM-IV Fourth Edition. 4th ed. Washington, DC: American Psychiatric Publishing, Inc; 1994:143.
30. Ferman TJ, Smith GE, Boeve BF, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006;20: 623-636.
31. Testa D, Fetoni V, Soliveri P, et al. Cognitive and motor performance in multiple system atrophy and Parkinson's disease compared. Neuropsychologia. 1993;31:207-210.
32. Oda H, Yamamoto Y, Maeda K. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2009;24:125-131.
33. Crowell TA, Luis CA, Cox DE, et al. Neuropsychological comparison of Alzheimer's disease and dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2007;23: 120-125.
34. Johnson DK, Morris JC, Galvin JE. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurology. 2005;65: 1232-1238.
35. Marui W, Iseki E, Nakai T, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci. 2002;195:153-159.
36. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology. 1991;41:1402-1409.
37. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78:36-42.
38. Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry. 2007;78: 1176-1181.
39. Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861-870.
40. Arrasate M, Mitra S, Schweitzer ES, et al. Inclusion body formation reduces levels of mutant Huntingtin and the risk of neuronal death. Nature. 2004;431:805-810.
41. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.